FIELD: medicine.
SUBSTANCE: method involves determining proinflammatory interleukines TNFα, IL-1α, anti-inflammatory interleukines Il-4, IL-10 in patients. Integral indices of proinflammatory interleukines (P1,P2) and anti-inflammatory interleukines (P3,P4) ratio of their content in patients to mean value determined for healthy people cases. Prognostic inflammation index is calculated as ratio of integral indices of proinflammatory interleukines (P1xP2) to anti-inflammatory interleukines indices (P3xP4). The value being equal to or greater than 1.4, pyoinflammatory complication progressive development is to be predicted. Otherwise favorable clinical course is predicted.
EFFECT: high accuracy of prognosis.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATION OF INFLAMMATORY PROCESS COURSE IN POSTOPERATIVE PERIOD | 2007 |
|
RU2352943C1 |
| METHOD OF FORECASTING PYOINFLAMMATORY COMPLICATIONS IN POST-OPERATION PERIOD | 2007 |
|
RU2349921C1 |
| METHOD FOR PREDICTING PYOINFLAMMATORY COMPLICATIONS IN TREATING THE CASES OF OPEN LONG TUBULAR BONE FRACTURES | 2004 |
|
RU2285925C2 |
| METHOD FOR PREDICTION OF DEVELOPING INFLAMMATORY PROCESS | 2009 |
|
RU2423694C2 |
| METHOD FOR ASSESSMENT OF CLINICAL COURSE OF WOUND PROCESS IN PATIENTS WITH DIABETIC FOOT SYNDROME | 2018 |
|
RU2696565C1 |
| METHOD OF LONG BONE FRACTURE CLASSIFICATION | 2010 |
|
RU2438564C1 |
| METHOD FOR PREDICTING PYO-INFLAMMATORY COMPLICATIONS | 2001 |
|
RU2193778C1 |
| MEDICINAL PRODUCT FOR THE TREATMENT OF ULCER DEFECTS IN "DIABETIC FOOT" SYNDROME | 2023 |
|
RU2804781C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF POST-RHINOPLASTY WOUND PROCESS | 2008 |
|
RU2377567C1 |
| METHOD FOR WOUND PROCESS COURSE PREDICTION | 2016 |
|
RU2627650C1 |
